BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 24331818)

  • 1. Burden of human papillomavirus infections and related diseases in the extended Middle East and North Africa region.
    Vaccarella S; Bruni L; Seoud M
    Vaccine; 2013 Dec; 31 Suppl 6():G32-44. PubMed ID: 24331818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of cervical cancer screening practices in the extended Middle East and North Africa countries.
    Sancho-Garnier H; Khazraji YC; Cherif MH; Mahnane A; Hsairi M; El Shalakamy A; Osgul N; Tuncer M; Jumaan AO; Seoud M
    Vaccine; 2013 Dec; 31 Suppl 6():G51-7. PubMed ID: 24331820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA).
    Kim JJ; Sharma M; O'Shea M; Sweet S; Diaz M; Sancho-Garnier H; Seoud M
    Vaccine; 2013 Dec; 31 Suppl 6():G65-77. PubMed ID: 24331822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of human papillomavirus-related cervical disease in the extended middle East and north Africa-a comprehensive literature review.
    Seoud M
    J Low Genit Tract Dis; 2012 Apr; 16(2):106-20. PubMed ID: 22371041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospects and challenges in the introduction of human papillomavirus vaccines in the extended Middle East and North Africa region.
    Jumaan AO; Ghanem S; Taher J; Braikat M; Al Awaidy S; Dbaibo GS
    Vaccine; 2013 Dec; 31 Suppl 6():G58-64. PubMed ID: 24331821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns and trends in human papillomavirus-related diseases in Central and Eastern Europe and Central Asia.
    Bray F; Lortet-Tieulent J; Znaor A; Brotons M; Poljak M; Arbyn M
    Vaccine; 2013 Dec; 31 Suppl 7():H32-45. PubMed ID: 24332296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexuality and sexual health: constructs and expressions in the extended Middle East and North Africa.
    El-Kak F
    Vaccine; 2013 Dec; 31 Suppl 6():G45-50. PubMed ID: 24331819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global burden of human papillomavirus and related diseases.
    Forman D; de Martel C; Lacey CJ; Soerjomataram I; Lortet-Tieulent J; Bruni L; Vignat J; Ferlay J; Bray F; Plummer M; Franceschi S
    Vaccine; 2012 Nov; 30 Suppl 5():F12-23. PubMed ID: 23199955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The burden of human papillomavirus infections and related diseases in sub-saharan Africa.
    De Vuyst H; Alemany L; Lacey C; Chibwesha CJ; Sahasrabuddhe V; Banura C; Denny L; Parham GP
    Vaccine; 2013 Dec; 31 Suppl 5(0 5):F32-46. PubMed ID: 24331746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe.
    Poljak M; Seme K; Maver PJ; Kocjan BJ; Cuschieri KS; Rogovskaya SI; Arbyn M; Syrjänen S
    Vaccine; 2013 Dec; 31 Suppl 7():H59-70. PubMed ID: 24332298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
    Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
    Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus epidemiology in populations with normal or abnormal cervical cytology or cervical cancer in the Middle East and North Africa: A systematic review and meta-analysis.
    Obeid DA; Almatrrouk SA; Alfageeh MB; Al-Ahdal MNA; Alhamlan FS
    J Infect Public Health; 2020 Sep; 13(9):1304-1313. PubMed ID: 32564935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burden and trends of type-specific human papillomavirus infections and related diseases in the Asia Pacific region.
    Parkin DM; Louie KS; Clifford G
    Vaccine; 2008 Aug; 26 Suppl 12():M1-16. PubMed ID: 18945410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
    Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
    Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa.
    Adefuye PO; Broutet NJ; de Sanjosé S; Denny LA
    Vaccine; 2013 Dec; 31 Suppl 5():F53-9. PubMed ID: 24331748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of human papillomavirus infection and related diseases in Israel.
    Shavit O; Roura E; Barchana M; Diaz M; Bornstein J
    Vaccine; 2013 Nov; 31 Suppl 8():I32-41. PubMed ID: 24229717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended Middle East and North Africa: summary recommendations for the prevention of human papillomavirus infections and related cancers including cervical cancer.
    Seoud M; Vaccarella S; El-Kak F; Sancho-Garnier H; Jumaan AO; Kim JJ; Garland SM; Stern PL; LaMontagne DS; Albero G; Bosch FX
    Vaccine; 2013 Dec; 31 Suppl 6():G78-9. PubMed ID: 24331823
    [No Abstract]   [Full Text] [Related]  

  • 19. Extended Middle East and North Africa: cervical cancer and human papillomavirus: can we make the case for prevention in this "relatively" low prevalence region?
    Seoud M
    Vaccine; 2013 Dec; 31 Suppl 6():vii-viii. PubMed ID: 24331825
    [No Abstract]   [Full Text] [Related]  

  • 20. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases.
    Clifford G; Franceschi S; Diaz M; Muñoz N; Villa LL
    Vaccine; 2006 Aug; 24 Suppl 3():S3/26-34. PubMed ID: 16950015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.